DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

100 Episodes

1. Key Factors for Choosing the Right CDMO

   Published: 8/28/2023
2. Strategies to Maximize Product Value Amid Loss of Exclusivity in the Pharmaceutical Industry

   Published: 8/21/2023
3. Unsuccessful Regulatory Filings for Biosimilar Approval: A Comprehensive Review

   Published: 8/15/2023
4. Drug Patent Reports now available on Amazon

   Published: 8/14/2023
5. Artificial Intelligence and Machine Learning in Drug Discovery and Development

   Published: 8/10/2023
6. Prevalence and timing of authorized generics in the US market

   Published: 8/8/2023
7. Insights into Shifting Dynamics: Orange Book and Biologic PTAB Trends

   Published: 8/7/2023
8. The Evolution of Reverse Payment Cases: Courts and Agencies’ Approaches in Pharma Litigation

   Published: 8/5/2023
9. Understanding the Impact of Authorized Generics on Drug Pricing: The Entacapone Case Study

   Published: 8/2/2023
10. Review of 505(b)(2) Drug Products Approved by USFDA from 2010 to 2020: A Focus on Intellectual Property and Regulatory Considerations

    Published: 7/28/2023
11. DrugPatentWatch reveals NIH funding for patents

    Published: 7/27/2023
12. Filing Strategies for Maximizing Pharma Patents

    Published: 7/25/2023
13. DrugChatter Featured Questions

    Published: 6/8/2023
14. DrugChatter.com: AI Chat for Biopharmaceutical Drug Insights

    Published: 5/22/2023
15. NPR and DrugPatentWatch – Can drug injector pens be swapped?

    Published: 5/16/2023
16. Utilizing 505(b)(2) Regulatory Pathway for New Drug Applications: An Overview on the Advanced Formulation Approach and Challenges

    Published: 4/19/2023
17. Social Return on Investment

    Published: 9/6/2022
18. CDCDB: A large and continuously updated drug combination database

    Published: 6/7/2022
19. DrugPatentWatch named “Best of the Web” by Genetic Engineering News

    Published: 5/2/2022
20. The value of method of use patent claims in protecting your therapeutic assets

    Published: 4/5/2022